221 related articles for article (PubMed ID: 33776712)
1. Idiopathic Hypereosinophilic Syndrome with Multiple Organ Involvement.
Abo Shdid R; Azrieh B; Alebbi S; Mansour S; Naeem M
Case Rep Oncol; 2021; 14(1):249-255. PubMed ID: 33776712
[TBL] [Abstract][Full Text] [Related]
2. A Diagnosis of Idiopathic Hypereosinophilic Syndrome With Skin Involvement in a Patient Presenting With Lymphadenopathy and Rash.
Sekar N; Umakanth M
Cureus; 2022 Mar; 14(3):e23580. PubMed ID: 35494909
[TBL] [Abstract][Full Text] [Related]
3. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib.
Fraticelli P; Kafyeke A; Mattioli M; Martino GP; Murri M; Gabrielli A
World J Clin Cases; 2016 Oct; 4(10):328-332. PubMed ID: 27803915
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with montelukast and ketotifen for arthritis and rash resulting from idiopathic hypereosinophilic syndrome.
Selvi E; Rubegni P; Manganelli S; De Stefano R; Frati E; Lorenzini S; Sbano P; Marcolongo R
J Clin Rheumatol; 2004 Dec; 10(6):344-6. PubMed ID: 17043546
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab.
Zhang Z; Sun Y; Chen SN
Front Pharmacol; 2023; 14():1095737. PubMed ID: 37361219
[TBL] [Abstract][Full Text] [Related]
7. Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.
Karnak D; Kayacan O; Beder S; Delibalta M
CMAJ; 2003 Jan; 168(2):172-5. PubMed ID: 12538545
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory idiopathic hypereosinophilic syndrome with etoposide.
Razaq W; Beautyman E
Am J Ther; 2009; 16(1):68-70. PubMed ID: 19142161
[TBL] [Abstract][Full Text] [Related]
9. An 85-Year-Old Man with Fever, Dyspnea, and Dry Cough Diagnosed with Idiopathic Hypereosinophilic Syndrome, Successfully Treated with High-Dose Corticosteroids.
Goyal P; Chhabra ST; Tandon R; Jaiswal B; Sharma N
Am J Case Rep; 2023 Dec; 24():e941241. PubMed ID: 38073150
[TBL] [Abstract][Full Text] [Related]
10. Hypereosinophilic syndrome with characteristic left ventricular thrombus demonstrated by contrast echocardiography.
Adams JC; Dal-Bianco JP; Kumar G; Callahan MJ
Neth Heart J; 2009 Apr; 17(4):169-70. PubMed ID: 19421363
[TBL] [Abstract][Full Text] [Related]
11. A case report of Löffler endocarditis in idiopathic hypereosinophilic syndrome: recovery is possible.
Abayazeed RM; Abdel-Hay MA; Elfwal S; Hssanein M
Eur Heart J Case Rep; 2018 Jun; 2(2):yty030. PubMed ID: 31020113
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Rothenberg ME; Klion AD; Roufosse FE; Kahn JE; Weller PF; Simon HU; Schwartz LB; Rosenwasser LJ; Ring J; Griffin EF; Haig AE; Frewer PI; Parkin JM; Gleich GJ;
N Engl J Med; 2008 Mar; 358(12):1215-28. PubMed ID: 18344568
[TBL] [Abstract][Full Text] [Related]
13. Cardiomegaly and Low Voltage Suggest Cardiac Involvement in a Patient With Hypereosinophilic Syndrome: A Case Report.
Kashima K; Ooi M; Yoshishige Y; Kawabata K
Cureus; 2023 May; 15(5):e39354. PubMed ID: 37362537
[TBL] [Abstract][Full Text] [Related]
14. FIP1L1-PDGFRA fusion-negative hypereosinophilic syndrome with uncommon cardiac involvement responding to imatinib treatment: A case report.
Dal Berto AS; Camiña RH; Machado ES; Baptistella AR
Mol Clin Oncol; 2018 Jul; 9(1):35-39. PubMed ID: 29977537
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic Hypereosinophilic Syndrome: A Case Report.
Agudo M; Santos F; Teixeira Reis A; Moura P; Marques S
Cureus; 2023 Jun; 15(6):e39964. PubMed ID: 37416031
[TBL] [Abstract][Full Text] [Related]
16. Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab.
Kay D; Ataya A; Liu X; Auerbach J; Urbine D
Respir Med Case Rep; 2018; 25():30-32. PubMed ID: 29998055
[TBL] [Abstract][Full Text] [Related]
17. [Current differential diagnosis of hypereosinophilic syndrome].
Dinić-Uzurov V; Lalosević V; Milosević I; Urosević I; Lalosević D; Popović S
Med Pregl; 2007; 60(11-12):581-6. PubMed ID: 18666600
[TBL] [Abstract][Full Text] [Related]
18. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
19. [Peripheral neuropathy and idiopathic hypereosinophilic syndrome: review of the literature apropos of a case with atypical presentation].
Rieder CR; De Castro JH; Saraiva JC; Hansel SS
Arq Neuropsiquiatr; 1991 Sep; 49(3):348-51. PubMed ID: 1807239
[TBL] [Abstract][Full Text] [Related]
20. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
Schwartz LB; Sheikh J; Singh A
Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
